Analytical Data
-
Gene name
SUC2
- Application
-
Alternative Names
Invertase 2; Saccharase; SUC2; Beta-fructofuranosidase 2
-
Species
Others
-
Source
P. pastoris
-
Tag
C-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P00724-1
-
Expression Region
S20-K532
-
Protein Length
Full Length of Isoform-1 Mature Protein
-
Molecular Weight
66 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SUC2, or sucrase-isomaltase, is a crucial enzyme involved in carbohydrate metabolism, primarily responsible for the hydrolysis of sucrose and isomaltose into fructose and glucose. Its significance extends beyond digestion; SUC2 plays a pivotal role in various physiological processes and has been implicated in several health conditions, including diabetes, obesity, and other metabolic disorders. Research into SUC2 recombination and its protein structure has gained considerable attention due to its potential therapeutic applications. Recombinant SUC2 proteins can be utilized in the development of novel treatments targeting metabolic diseases, enabling the modulation of carbohydrate absorption and energy regulation. Moreover, understanding the intricate mechanisms of SUC2's enzymatic activity at the molecular level can pave the way for the design of specific inhibitors or enhancers, further expanding its role in therapeutic interventions. Advances in genetic engineering and biotechnology have facilitated the production of recombinant SUC2 proteins, leading to improved purification techniques and functional assays. Researchers are also exploring the enzyme's structure-function relationships through techniques such as X-ray crystallography and molecular modeling, which could provide insights into its interaction with substrates and inhibitors. Consequently, the study of SUC2 and its recombinant forms represents a promising frontier in both basic and applied sciences, offering avenues for innovative strategies to combat metabolic diseases and enhance our understanding of human metabolism.
